DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Piramal Pharma Limited — Analyst/Investor Meet Para A-XBRL

NSE 1 hr ago·28 Oct 2026, 11:18 am

Piramal Pharma

PIRAMAL PHARMA LIMITED has informed the Exchange about Audio Recording/Video Recording

Affected stocks

Neutral1 stock

Piramal Pharma

PPLPHARMA Neutral

₹198.72

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

Concerns Piramal Pharma (PPLPHARMA).
Category: Company.

Why it matters

A routine update for Piramal Pharma. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Company SEBI

Prohibitory Order no.1577/2026 issued against Annaswamy Venkatramani (PAN: AABPV3960F) under Recovery Certificate Nos. 2976 of 2020, 3197 of 2020 and 6606 of 2023

SEBI · 16 min ago